Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill: business and regulatory impact assessment
A business and regulatory impact assessment for the introduction of the Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill.
Footnotes
1. CMO(2018)10 - Transvaginal mesh (scot.nhs.uk)
CMO(2018)12 - Restricted Use Protocol for interventions to treat stress urinary incontinence and pelvic organ prolapse (scot.nhs.uk)
2. the Independent Medicines and Medical Devices safety Review (immdsreview.org.uk)
3. The Alliance is the national third sector intermediary for a range of health and social care organisations. They are a strategic partner of the Scottish Government and have fed into several mesh policy developments including the development of the Complex Mesh Removal Service in NHS GGC and the Scottish Government mesh fund.
Contact
Email: erin.fyfe@gov.scot
There is a problem
Thanks for your feedback